Comments on "Simoens, S. Health economic assessment: a methodological primer. Int. J. Environ. Res. Public Health 2009, 6, 2950-2966"-New Zealand in fact has no cost-effectiveness threshold.
about
Identifying priority medicines policy issues for New Zealand: a general inductive study.Systematic overview of cost-effectiveness thresholds in ten countries across four continents.Health economic assessment: cost-effectiveness thresholds and other decision criteria.Comment on "ahead of its time? Reflecting on New Zealand's Pharmac following its 20th anniversary" : clarification from PHARMAC: PHARMAC takes no particular distributive approach (utilitarian or otherwise).
P2860
Comments on "Simoens, S. Health economic assessment: a methodological primer. Int. J. Environ. Res. Public Health 2009, 6, 2950-2966"-New Zealand in fact has no cost-effectiveness threshold.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Comments on "Simoens, S. Healt ...... cost-effectiveness threshold.
@en
type
label
Comments on "Simoens, S. Healt ...... cost-effectiveness threshold.
@en
prefLabel
Comments on "Simoens, S. Healt ...... cost-effectiveness threshold.
@en
P2860
P356
P1476
Comments on "Simoens, S. Healt ...... cost-effectiveness threshold.
@en
P2093
Rachel Grocott
Scott Metcalfe
P2860
P304
P356
10.3390/IJERPH7041831
P577
2010-04-20T00:00:00Z